Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 601, Issue 1-2, 2006, Pages 46-50

  Tamimi, Yahya ^a   Dietrich, Kevin ^a   Stone, Kathryn ^a   Grundy, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Denaturing HPLC; Mutation analysis; PAX 2 gene; PAX 8 gene; Wilms tumor

Indexed keywords

TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRON; MUTATION RATE; MUTATIONAL ANALYSIS; NEPHROBLASTOMA; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXONS; GENE FREQUENCY; HUMANS; KIDNEY NEOPLASMS; MUTATION; PAIRED BOX TRANSCRIPTION FACTORS; PAX2 TRANSCRIPTION FACTOR; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; WILMS TUMOR;

EID: 33749536202     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.05.025     Document Type: Article

References (32)

1. Breslow N.E., and Beckwith J.B. Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study. J. Natl. Cancer Inst. 68 (1982) 429-436
2. Breslow N.E., Olson J., Moksness J., Beckwith J.B., and Grundy P. Familial Wilms' tumor: a descriptive study. Med. Pediatr. Oncol. 27 (1996) 398-403
3. Pelletier J., Schalling M., Buckler A.J., Rogers A., Haber D.A., and Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5 (1991) 1345-1356
4. Hastie N.D. The genetics of Wilms' tumor-a case of disrupted development. Annu. Rev. Genet. 28 (1994) 523-558
5. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., Rose E.A., Kral A., Yeger H., Lewis W.H., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60 (1990) 509-520
6. Coppes M.J., Campbell C.E., and Williams B.R. The role of WT1 in Wilms tumorigenesis. FASEB J. 7 (1993) 886-895
7. Li C.M., Kim C.E., Margolin A.A., Guo M., Zhu J., Mason J.M., Hensle T.W., Murty V.V., Grundy P.E., Fearon E.R., D'Agati V., Licht J.D., and Tycko B. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am. J. Pathol. 165 (2004) 1943-1953
8. Yeh A., Wei M., Golub S.B., Yamashiro D.J., Murty V.V., and Tycko B. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene. Genes Chromosomes Cancer 35 (2002) 156-163
9. Dressler G.R., and Douglass E.C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 1179-1183
10. Eccles M.R., Wallis L.J., Fidler A.E., Spurr N.K., Goodfellow P.J., and Reeve A.E. Expression of the PAX-2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ. 3 (1992) 279-289
11. Gnarra J.R., and Dressler G.R. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 55 (1995) 4092-4098
12. Khoubehi B., Kessling A.M., Adshead J.M., Smith G.L., Smith R.D., and Ogden C.W. Expression of the developmental and oncogenic PAX-2 gene in human prostate cancer. J. Urol. 165 (2001) 2115-2120
13. Kroll T.G., Sarraf P., Pecciarini L., Chen C.J., Mueller E., Spiegelman B.M., and Fletcher J.A. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289 (2000) 1357-1360
14. Poleev A., Wendler F., Fickenscher H., Zannini M.S., Yaginuma K., Abbott C., and Plachov D. Distinct functional properties of three human paired-box-protein, PAX-8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors. Eur. J. Biochem. 228 (1995) 899-911
15. Silberstein G.B., Dressler G.R., and Van Horn K. Expression of the PAX-2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene 21 (2002) 1009-1016
16. Treisman J., Harris E., and Desplan C. The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev. 5 (1991) 594-604
17. Eccles M.R., Yun K., Reeve A.E., and Fidler A.E. Comparative in situ hybridization analysis of PAX-2, PAX-8, and WT1 gene transcription in human fetal kidney and Wilms' tumors. Am. J. Pathol. 146 (1995) 40-45
18. Bouchard M., Souabni A., Mandler M., Neubuser A., and Busslinger M. Nephric lineage specification by Pax-2 and Pax-8. Genes Dev. 16 (2002) 2958-2970
19. Grundy P.E., Breslow N.E., Li S., Perlman E., Beckwith J.B., Ritchey M.L., Shamberger R.C., Haase G.M., D'Angio G.J., Donaldson M., Coppes M.J., Malogolowkin M., Shearer P., Thomas P.R., Macklis R., Tomlinson G., Huff V., and Green D.M. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J. Clin. Oncol. 23 (2005) 7312-7321
20. Macchia P.E., Lapi P., Krude H., Pirro M.T., Missero C., Chiovato L., Souabni A., Baserga M., Tassi V., Pinchera A., Fenzi G., Gruters A., Busslinger M., and Di Lauro R. PAX-8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat. Genet. 19 (1998) 83-86
21. Schimmenti L.A., Cunliffe H.E., McNoe L.A., Ward T.A., French M.C., Shim H.H., Zhang Y.H., Proesmans W., Leys A., Byerly K.A., Braddock S.R., Masuno M., Imaizumi K., Devriendt K., and Eccles M.R. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX-2 mutations. Am. J. Hum. Genet. 60 (1997) 869-878
22. Vilain C., Rydlewski C., Duprez L., Heinrichs C., Abramowicz M., Malvaux P., Renneboog B., Parma J., Costagliola S., and Vassart G. Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX-8. J. Clin. Endocrinol. Metab. 86 (2001) 234-238
23. Dressler G.R. Pax-2, kidney development, and oncogenesis. Med. Pediatr. Oncol. 27 (1996) 440-444
24. Chen H., Wilkins L.M., Aziz N., Cannings C., Wyllie D.H., Bingle C., Rogus J., Beck J.D., Offenbacher S., Cork M.J., Rafie-Kolpin M., Hsieh C.M., Kornman K.S., and Duff G.W. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet. 15 (2006) 519-529
25. Wittwer J., Marti-Jaun J., and Hersberger M. Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1. Hum. Mutat. 27 (2006) 78-87
26. Zhang X., Miao X., Guo Y., Tan W., Zhou Y., Sun T., Wang Y., and Lin D. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum. Mutat. 27 (2006) 110-117
27. Colley J., Jones S., Dallosso A.R., Maynard J.H., Humphreys V., Dolwani S., Sampson J.R., and Cheadle J.P. Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic Navigator software. Hum. Mutat. 26 (2005) 165
28. Jones A.C., Austin J., Hansen N., Hoogendoorn B., Oefner P.J., Cheadle J.P., and O'Donovan M.C. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin. Chem. 45 (1999) 1133-1140
29. Xiao W., and Oefner P.J. Denaturing high-performance liquid chromatography: a review. Hum. Mutat. 17 (2001) 439-474
30. Grote D., Souabni A., Busslinger M., and Bouchard M. Pax2/8-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133 (2006) 53-61
31. Lakshmanan G., Lieuw K.H., Lim K.C., Gu Y., Grosveld F., Engel J.D., and Karis A. Localization of distant urogenital system-, central nervous system-, and endocardium-specific transcriptional regulatory elements in the GATA-3 locus. Mol. Cell Biol. 19 (1999) 1558-1568
32. Tamimi Y., Lines M., Coca-Prados M., and Walter M.A. Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3904-3913